Variant report
Variant | nsv8067 |
---|---|
Chromosome Location | chr7:19548204-19550157 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576007650 | chr7:19548204-19548205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs140300426 | chr7:19548242-19548243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114624149 | chr7:19548245-19548246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs144473833 | chr7:19548297-19548298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs28482990 | chr7:19548302-19548303 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs561791599 | chr7:19548336-19548337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528918990 | chr7:19548360-19548361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs17141503 | chr7:19548451-19548452 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs147855217 | chr7:19548500-19548501 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183034477 | chr7:19548516-19548517 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551211790 | chr7:19548547-19548548 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571330378 | chr7:19548579-19548580 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs570950387 | chr7:19548586-19548587 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566349279 | chr7:19548620-19548621 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533705504 | chr7:19548624-19548625 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553225772 | chr7:19548641-19548642 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11543656 | chr7:19548656-19548657 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs143650542 | chr7:19548659-19548660 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535527658 | chr7:19548719-19548720 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557315115 | chr7:19548729-19548730 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192834688 | chr7:19548744-19548745 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546523441 | chr7:19548754-19548755 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs374397111 | chr7:19548785-19548786 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs4721778 | chr7:19548842-19548843 | Enhancers Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs116670532 | chr7:19548843-19548844 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540808487 | chr7:19548872-19548873 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs561660382 | chr7:19548879-19548880 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142632174 | chr7:19548886-19548887 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs386710953 | chr7:19548906-19548907 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs4721780 | chr7:19548908-19548909 | Enhancers Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs146275140 | chr7:19548939-19548940 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368548297 | chr7:19548943-19548944 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112589558 | chr7:19548975-19548976 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs35579648 | chr7:19548976-19548977 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs201470145 | chr7:19548994-19548995 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs4719563 | chr7:19549012-19549013 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs116267696 | chr7:19549017-19549018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112470205 | chr7:19549035-19549036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549155996 | chr7:19549049-19549050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183069327 | chr7:19549053-19549054 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs535955162 | chr7:19549068-19549069 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557129139 | chr7:19549117-19549118 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144981714 | chr7:19549123-19549124 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138785985 | chr7:19549127-19549128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558525977 | chr7:19549132-19549133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs187768514 | chr7:19549136-19549137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs540519023 | chr7:19549141-19549142 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555935508 | chr7:19549156-19549157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs4719564 | chr7:19549162-19549163 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs62446652 | chr7:19549163-19549164 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Cancer | 21183584 | CNVD |
Autism | 20808228 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:19547600-19548600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr7:19547600-19548600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr7:19547600-19549000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr7:19547800-19548400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr7:19547800-19548600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr7:19547800-19548800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr7:19547800-19548800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
8 | chr7:19547800-19549000 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr7:19548000-19548800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr7:19548000-19548800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
11 | chr7:19548000-19548800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr7:19548000-19549600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr7:19548200-19548600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr7:19548400-19548800 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
15 | chr7:19548400-19549000 | Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
16 | chr7:19548600-19548800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr7:19548800-19549400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
18 | chr7:19548800-19559000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |